Evidence map›Paper›PMID 35429459›Full record

ArticleCell chemical biology2022

Cellular signals converge at the NOX2-SHP-2 axis to induce reductive carboxylation in cancer cells.

Rukang Zhang, Dong Chen, Hao Fan, Rong Wu, Jiayi Tu, Freya Q Zhang, Mei Wang, Hong Zheng, Cheng-Kui Qu, Shannon E Elf and 6 more

Open access · greenAbstract read
In one paragraph

Article in Cell chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Rukang ZhangDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Dong ChenDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hao FanDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Rong WuDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Jiayi TuDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Freya Q ZhangDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Mei WangDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Hong ZhengDepartment of Pediatrics and Aflac Cancer and Blood Disorder Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Cheng-Kui QuDepartment of Pediatrics and Aflac Cancer and Blood Disorder Center, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.
Shannon E ElfThe Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
Brandon FaubertDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Yu-Ying HeDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Marc B BissonnetteDepartment of Medicine, The University of Chicago, Chicago, IL 60637, USA.
Xue GaoDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. Electronic address: xgao30@uchicago.edu.
Ralph J DeBerardinisUT Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address: ralph.deberardinis@utsouthwestern.edu.
Jing ChenDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA; Department of Medicine, The University of Chicago, Chicago, IL 60637, USA. Electronic address: jingchen@medicine.bsd.uchicago.edu.
Emory University · USUniversity of Chicago · USSouthwestern Medical Center · US

Funding

Multi-Disciplinary Training Grant in Cancer ResearchT32CA009594 · NCI · UNIVERSITY OF CHICAGO · PI KAY F MACLEOD, Scott A. Oakes · 1989 to 2026
$11.5M
Metabolic Regulators of Tumor Growth and ProgressionR35CA220449 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI RALPH J DEBERARDINIS · 2017 to 2026
$9.4M
Tyrosine Kinase Signaling in Cancer Cell MetabolismR01CA140515 · NCI · UNIVERSITY OF CHICAGO · PI Jing Chen · 2010 to 2026
$5.4M
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human CancersR01CA174786 · NCI · UNIVERSITY OF CHICAGO · PI CHEN, JING · 2014 to 2024
$3.7M
The mechanistic role of METTL14 in UVB-induced skin tumorigenesisR01ES030576 · NIEHS · UNIVERSITY OF CHICAGO · PI HE, YU-YING · 2019 to 2023
$3.0M
CXCR4 as a target for colon cancer chemopreventionR01CA240710 · NCI · UNIVERSITY OF CHICAGO · PI BISSONNETTE, BRUCE MARC · 2019 to 2023
$1.8M
Dietary trans-vaccenic acid enhances anti-tumor immunityR01CA276568 · NCI · UNIVERSITY OF CHICAGO · PI Jing Chen · 2023 to 2026
$1.5M
NCI NIH HHS R01 CA140515NCI NIH HHS R01 CA174786NCI NIH HHS R01 CA240710NCI NIH HHS R01 CA276568NCI NIH HHS R35 CA220449NCI NIH HHS T32 CA009594NIEHS NIH HHS R01 ES030576
6 · The paper itself

Abstract

Environmental stresses, including hypoxia or detachment for anchorage independence, or attenuation of mitochondrial respiration through inhibition of electron transport chain induce reductive carboxylation in cells with an enhanced fraction of citrate arising through reductive metabolism of glutamine. This metabolic process contributes to redox homeostasis and sustains biosynthesis of lipids. Reductive carboxylation is often dependent on cytosolic isocitrate dehydrogenase 1 (IDH1). However, whether diverse cellular signals induce reductive carboxylation differentially or through a common signaling converging node remains unclear. We found that induction of reductive carboxylation commonly requires enhanced tyrosine phosphorylation and activation of IDH1, which, surprisingly, is achieved by attenuation of a cytosolic protein tyrosine phosphatase, Src homology region 2 domain-containing phosphatase-2 (SHP-2). Mechanistically, diverse signals induce reductive carboxylation by converging at upregulation of NADPH oxidase 2, leading to elevated cytosolic reactive oxygen species that consequently inhibit SHP-2. Together, our work elucidates the signaling basis underlying reductive carboxylation in cancer cells.

Indexed as

Isocitrate DehydrogenaseNeoplasmsCell Line, TumorCitric Acid CycleGlutamineOxidation-ReductionPhosphorylationProtein Tyrosine Phosphatase, Non-Receptor Type 11GlutamineIsocitrate DehydrogenaseProtein Tyrosine Phosphatase, Non-Receptor Type 11cytosolic reactive oxygen species (ROS)isocitrate dehydrogenase 1 (IDH1)NADPH oxidase 2 (NOX2)reductive carboxylationSrc homology region 2 domain-containing phosphatase-2 (SHP-2)tyrosine phosphorylation

Identifiers

PMID35429459
PMCPMC9308720
OpenAlexW4224011690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.